2020
DOI: 10.1016/j.clinbiochem.2020.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Label-free peptide quantification coupled with in silico mapping of proteases for identification of potential serum biomarkers in gastric adenocarcinoma patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 66 publications
0
8
0
Order By: Relevance
“…Protein fold changes (FC) of at least 1.5 were obtained, and P < 0.05 was considered a statistically significant difference. A FC < 1.5 represented upregulated proteins and a FC < 0.667 represented downregulated proteins; a FC between 0.667 and 1.5 indicated no obvious change in protein expression between the two groups ( Morrissey et al, 2013 ; Oliveira et al, 2020 ; Rawat et al, 2016 ).…”
Section: Methodsmentioning
confidence: 99%
“…Protein fold changes (FC) of at least 1.5 were obtained, and P < 0.05 was considered a statistically significant difference. A FC < 1.5 represented upregulated proteins and a FC < 0.667 represented downregulated proteins; a FC between 0.667 and 1.5 indicated no obvious change in protein expression between the two groups ( Morrissey et al, 2013 ; Oliveira et al, 2020 ; Rawat et al, 2016 ).…”
Section: Methodsmentioning
confidence: 99%
“…A number of serum peptidome studies have described distinctive FpA patterns associated to clinically-relevant outcomes; however, their biological significance in the blood of cancer patients is still debated. Although FpA-derived fragments were mainly found overexpressed in cancer patients [ 18 , 50 , 51 , 52 , 53 ], a downmodulation has also been associated with several cancer conditions [ 52 , 54 ]. In 2006 Villanueva et al published a study in which lower levels of FpA-derived fragments were found in serum from patients affected by prostate, bladder and breast cancer [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…The relative quantification levels of proteins in both replicates of experimental samples significantly different from control samples ( p values <0.05) and with fold changes (FCs) ≥1.5 were considered upregulated proteins, whereas those with FC ≤0.667 were considered downregulated proteins. A FC between 0.667 and 1.5 or with p > 0.05 indicated no change in protein expression between the two groups 16–18 …”
Section: Methodsmentioning
confidence: 99%
“…A FC between 0.667 and 1.5 or with p > 0.05 indicated no change in protein expression between the two groups. 16 , 17 , 18 …”
Section: Methodsmentioning
confidence: 99%